News | Pediatric Cardiology | January 06, 2023

New Pediatric Investigation Article Reviews the Potential of Transcatheter Pulmonary Valve Replacement for Congenital Heart Disorders

Heart patients with a dysfunctional or leaky pulmonary valve can benefit from a non-surgical procedure called transcatheter pulmonary valve replacement

The ensemble delivery system of the Melody valve.

The ensemble delivery system of the Melody valve.

January 6, 2023 — Patients with congenital heart diseases often suffer from obstructions in the right ventricular outflow tract (RVOT), which carries blood from the heart to the lungs. These obstructions can be repaired with surgical procedures. However, these are temporary fixes that can still result in pulmonary stenosis and/or regurgitation, eventually leading to RVOT dysfunction and even fatal arrhythmias. Often, heart patients require pulmonary valve replacement (PVR) surgery; using bioprosthetic valves made from materials derived from cows or pigs, which deteriorate over time. This results in patients needing valve replacement surgeries throughout their lives, which increases the risk of surgical complications. To minimize the need for multiple surgeries and their resultant risks, medical researchers have been trying to find robust alternatives to surgical PVR. To this end, transcatheter PVR (TPVR) has emerged as a potential non-surgical option to restore RVOT and pulmonary valve functions without the concomitant surgical risks.

In this review article, Professor Adolphus Kai-Tung Chau from the Chinese University of Hong Kong Medical Centre discusses the benefits, challenges, clinical considerations, outcomes, and developments in the application of TPVR. The article was made available online on December 5, 2022, in an Early View version of Pediatric InvestigationDifferent cardiology societies may adopt slightly different criteria for TPVR for both symptomatic and asymptomatic patients. But given that this procedure is minimally invasive compared to surgical PVR, it is likely that more asymptomatic patients may benefit from it,” says Prof. Chau.

The TPVR procedure requires a thorough pre-procedural evaluation, including patient history, physical examination, chest radiographs, electro- and echo-cardiograms, and imaging tests to ascertain the morphology of the RVOT and the presence of existing pulmonary complications. The surgical plan for individual patients is ideally determined by a multidisciplinary team of specialists.

Before the procedure, anatomical and hemodynamic data are assessed along with the assessment of the coronary artery and aorta. Next, the RVOT conduit is prepared for the implantation with pre-stenting and serial balloon dilation to ensure adequate pressure in the right ventricle and avoid valve failure.

What makes the TPVR procedure minimally invasive? Unlike conventional open-heart surgery, TPVR is conducted by guiding a hollow transcatheter tube through the femoral or jugular vein into the heart. The valve is implanted and set in position via balloon dilation. Following the implant, post-procedure hemodynamic data and angiograms are obtained to assess valve competence and check for perivalvular leak.

An advantage of the TPVR is that it can also be safely used for valve-in-valve conditions, where a new transcatheter valve is placed inside the hole of the failed valve after minor alterations.

Lately, trials are being conducted to adapt the application of TPVR for valve implantation in native, large, or variably shaped RVOTs, through self-expanding, partially covered stents that can fit into a wide range of RVOT shapes and sizes.

As of now, the Harmony and Edward Sapien valves are the only TPVR-compatible valves approved by the United States Food and Drug Administration (FDA). However, newer valves are continuously being developed and tested with promising results.

Long-term results indicate that TPVR can effectively restore RVOT function, while improving survival rates and reducing the need for reintervention across age groups. Nevertheless, vigilant testing is recommended to avoid endocarditis and coronary artery compression, which are rare but serious complications of TPVR. Although TPVR and surgical PVR have similar outcomes in terms of mortality rates and cardiovascular readmissions, TPVR leads to shorter hospital stays that benefit both patients and their caregivers.

In conclusion, this less invasive procedure is capable of providing safe and durable long-term outcomes, which makes it an important and preferred option for patients with congenital heart diseases. “TPVR is constantly evolving and undergoing improvement in efficacy and safety. With more long-term results from trials and better delivery systems, TPVR might also be useful as an initial repair option for younger and growing children,” envisions Prof. Chau. 

For more information:

Recent Technology Advances in Congenital Heart:

FDA Clears First Device to Treat Right Ventricular Outflow Tract Congenital Heart Disease 

VIDEO: Harmony Transcatheter Pulmonary Valve Has Good Outcomes at 1 Year — Interview with Tom Jones, M.D.

Medtronic Harmony Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year

FDA Expands Indication for Melody Transcatheter Valve for Failed Surgical Valves

VIDEO: Use of Virtual Reality to Aid Congenital Heart Disease — Interview with David M. Axelrod, M.D.

Bioresorbable Pulmonary Valve Replacement May Enable Cardiovascular Regeneration

VIDEO: Transcatheter Closure of Holes in the Heart — Interview with Ziyad Hijazi, M.D.

Nemours Children's Health System Uses 3-D Printing to Deliver Personalized Care

Children's Hospital Los Angeles Cardiologist Creates Modified Stent for 18-month-old Using Printed 3-D Model

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials

Bioresorbable ASD Occluder Prepares to Enter U.S. Clinical Trial

FDA Approves Abbott's Amplatzer Piccolo Occluder

Critical Need for Pediatric Electrophysiology Devices is Focus of Medical Device Competition 

Lab-created Heart Valves Can Grow With the Patient

SCAI Issues Position Statement on Adult Congenital Cardiac Interventional Training, Competencies and Organizational Recommendations

Abbott Receives European CE Mark for Two Pediatric Heart Devices

ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease

Find more congenital heart disease (CHD) content

Related Content

News | Pediatric Cardiology

January 27, 2023 — Cincinnati Children’s Hospital Medical Center is excited to announce the opening of its Heart and ...

Home January 27, 2023
News | Pediatric Cardiology

December 16, 2022 — Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when she ...

Home December 16, 2022
News | Pediatric Cardiology

November 25, 2022 — Jodie Votava-Smith, MD, has pulled up two side-by-side echocardiograms on her computer screen and is ...

Home November 25, 2022
News | Pediatric Cardiology

November 23, 2022 — Cardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular problems ...

Home November 23, 2022
News | Pediatric Cardiology

November 14, 2022 — For more than four decades, doctors have been split on whether giving steroids during a pediatric ...

Home November 14, 2022
News | Pediatric Cardiology

October 27, 2022 — Elite young athletes are set to benefit from a novel screening tool with the potential to change ...

Home October 27, 2022
News | Pediatric Cardiology

September 28, 2022 — Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before ...

Home September 28, 2022
News | Pediatric Cardiology

September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable Cardiac ...

Home September 20, 2022
News | Pediatric Cardiology

July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as ...

Home July 13, 2022
News | Pediatric Cardiology

July 1, 2022 — Most children and adolescents living in the U.S. have suboptimal scores for cardiovascular health (CVH) ...

Home July 01, 2022
Subscribe Now